EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease
BioArctic AB's partner Eisai says the European Medicines Agency (EMA) has accepted a marketing authorization…
January 27, 2023 - 2 minutes
Biogen
‘Best hope yet’ as results from Alzheimer’s drug trial reveal huge step forward
A huge step forward in dementia research has been hailed a truly historic moment by…
November 30, 2022 - 6 minutes
Positive results from Eisai and Biogen Alzheimer’s trial
Eisai Co., Ltd. and Biogen Inc. have announced positive topline results from Eisai’s large global…
September 29, 2022 - 6 minutes
FDA Approval of Biogen’s Drug Boosts European Alzheimer’s Space
The FDA shocked many life sciences observers by greenlighting Biogen’s treatment candidate for Alzheimer’s last…
June 17, 2021 - 6 minutes
EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
April 27, 2021 - 6 minutes
Atlantic Healthcare’s Inflammatory Bowel Disease RNA Drug Fails Phase III
Hopes of seeing an approved treatment for the inflammatory bowel condition pouchitis have been dashed…
August 1, 2019 - 2 minutes
Biogen Acquires UK Biotech Developing Gene Therapy for Blindness
The big US biotech Biogen has agreed to acquire Nightstar Therapeutics for €773M ($877M), including…
March 4, 2019 - 2 minutes
Swiss Genomics Firm, Biogen and Microsoft Team Up to Treat Multiple Sclerosis
BC Platforms and Microsoft will be working with Biogen and the Accelerated Cure Project to…
October 16, 2017 - 3 minutes
How Close Are We to Curing ALS? A Review of Biotech’s Efforts
May 5, 2017, saw the first FDA approval for an amyotrophic lateral sclerosis (ALS) drug…
October 3, 2017 - 8 minutes
German Biotech Unveils Positive Phase II Results for Alzheimer’s
Probiodrug has disclosed encouraging results of its latest Phase IIa trial to assess its lead…
June 12, 2017 - 3 minutes
How Biotech is Mastering Multiple Sclerosis: A Review
With last month’s FDA approval, Ocrevus (ocrelizumab), became the first drug for primary-progressive multiple sclerosis.…
April 25, 2017 - 7 minutes
Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?
Hopes for an Alzheimer’s cure took a hit with Eli Lilly’s recent failure, but it’s…
December 19, 2016 - 7 minutes
